From the Desk of the CEO

Community pharmacy is undergoing a seismic shift as we face a reality in which pharmacists are being asked to do more with less.

Ilisa BG Bernstein PharmD, JD, FAPhA

September means back to school for many, and recently I visited my alma mater in Michigan. As I drove back home to Washington, DC, I passed through a couple of different states. I thought of the pharmacists in each of these states dealing with disparate federal and state laws and regulations, and I thought of how APhA was making a difference for these pharmacists.

Ilisa BG Bernstein PharmD, JD, FAPhA

It’s been a busy summer in our nation’s capital, and in state capitals across the country. FDA’s monumental update to the EUA providing patient access to pharmacist services across this country gave pharmacists the ability to prescribe the COVID-19 oral antiviral, Paxlovid (Pfizer), under certain conditions for patients with COVID-19.

Ilisa BG Bernstein PharmD, JD, FAPhA

We finally got an important win in our fight to revamp the abusive and costly practices of retroactive direct and indirect remuneration (DIR) fees in the Medicare Part D program!

Scott J. Knoer, MS, PharmD, FASHP, APhA EVP and CEO

It was amazing to see everyone in San Antonio at the first pharmacy-wide in-person meeting since 2019! Wow! I was astounded at what I saw!

Scott J. Knoer, MS, PharmD, FASHP, APhA EVP and CEO